Evidence map›Paper›PMID 37569501›Full record

ArticleInternational journal of molecular sciences2023

Developing New Diagnostic Tools Based on SERS Analysis of Filtered Salivary Samples for Oral Cancer Detection.

Rareș-Mario Borșa, Valentin Toma, Anca Onaciu, Cristian-Silviu Moldovan, Radu Mărginean, Diana Cenariu, Gabriela-Fabiola Știufiuc, Cristian-Mihail Dinu, Simion Bran, Horia-Octavian Opriș and 6 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rareș-Mario BorșaDental Medicine Faculty, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania.ORCID 0009-0007-1754-2681
Valentin TomaResearch Center for Advanced Medicine-MedFuture, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania.ORCID 0000-0001-8322-1180
Anca OnaciuResearch Center for Advanced Medicine-MedFuture, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania.
Cristian-Silviu MoldovanResearch Center for Advanced Medicine-MedFuture, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania.ORCID 0000-0003-2927-4622
Radu MărgineanResearch Center for Advanced Medicine-MedFuture, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania.
Diana CenariuResearch Center for Advanced Medicine-MedFuture, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania.
Gabriela-Fabiola ȘtiufiucFaculty of Physics, "Babes Bolyai" University, Kogalniceanu 1, 400084 Cluj-Napoca, Romania.
Cristian-Mihail DinuDental Medicine Faculty, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania.
Simion BranDental Medicine Faculty, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania.
Horia-Octavian OprișDental Medicine Faculty, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania.ORCID 0000-0001-6123-4538
Sergiu VăcărașDental Medicine Faculty, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania.
Florin Onișor-GligorDental Medicine Faculty, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania.ORCID 0000-0003-1076-7726
Dorin SenteaCounty Emergency Hospital Cluj, Clinicilor 3-5, 400006 Cluj-Napoca, Romania.
Mihaela-Felicia BăciuțDental Medicine Faculty, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4, 400349 Cluj-Napoca, Romania.
Cristina-Adela IugaResearch Center for Advanced Medicine-MedFuture, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania.ORCID 0000-0002-0345-0993
Rareș-Ionuț ȘtiufiucResearch Center for Advanced Medicine-MedFuture, "Iuliu Hatieganu" University of Medicine and Pharmacy, Pasteur 4-6, 400337 Cluj-Napoca, Romania.ORCID 0000-0001-6769-1545

Funding

"Iuliu Hațieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania 35/194/17.12.2021
6 · The paper itself

Abstract

Cancer still represents one of the biggest challenges in current medical practice. Among different types of cancer, oral cancer has a huge impact on patients due to its great visibility, which is more likely to create social stigma and increased anxiety. New early diagnose methods are still needed to improve treatment efficiency and patients' life quality. Raman/SERS (Surface Enhanced Raman Spectroscopy) spectroscopy has a unique and powerful potential for detecting specific molecules that can become priceless biomarkers in different pathologies, such as oral cancer. In this study, a batch of saliva samples obtained from a group of 17 patients with oro-maxillofacial pathologies compared with saliva samples from 18 healthy donors using the aforementioned methods were evaluated. At the same time, opiorphin, potassium thiocyanate and uric acid were evaluated as potential specific biomarkers for oro-maxillofacial pathologies using multivariate analysis. A careful examination of SERS spectra collected on saliva samples showed that the spectra are dominated by the vibrational bands of opiorphin, potassium thiocyanate and uric acid. Given the fact that all these small molecules are found in very small amounts, we filtrated all the samples to get rid of large molecules and to improve our analysis. By using solid plasmonic substrates, we were able to gain information about molecular concentration and geometry of interaction. On the other hand, the multivariate analysis of the salivary spectra contributed to developing a new detection method for oral cancer.

Indexed as

Mouth NeoplasmsUric AcidBiomarkersHumansSpectrum Analysis, RamanThiocyanatesBiomarkerspotassium thiocyanateThiocyanatesUric Acidbiomarkersmultivariate analysisopiorphinoral cancerplasmonic substratespotassium thiocyanateRAMAN/SERS spectroscopyuric acid

Identifiers

PMID37569501
PMCPMC10418512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.